Back

C Suite Market Update - March 2014

March 2014

CEO turnover for March 2014 was down 7% from March last year. However, CFO turnover was up 22% and overall C level and Board of Director turnover were both up 9% over last year. February to March 2014 changes showed a minor decline in CEO turnover (2%) with an increase realized for CFO’s (13%), an  increase in overall C Level changes (6%) and an increase in Board of Director changes (16%)

Executive turnover activities break down as follows:

  • CEO changes, -7%   A total of 164 changes with the largest number of changes occurring in banking, drug/biotech and metals/mining. Last month’s changes occurred primarily in energy, manufacturing and consumer products.
  • CFO changes,  +22%   A total of 166 changes with the largest number of changes occurring in drugs/biotech, metals/mining and banking. Last month’s changes occurred primarily in drugs/bio tech, health services and telecom
  • Board of Directors,  +16%   A total of 497 changes with the largest number of changes occurring in drugs/biotech, energy and banking. Last month’s changes occurred in the same sectors.
  • Overall C suite, +6%.  A total of 1355 changes with the largest number of changes occurring in drugs/biotech, energy and banking. Last month’s changes occurred in the same sectors.

This growth in turnover in the executive ranks is reflective of the overall gradual improvement in the economy. Underperforming companies are more inclined to make changes as the economy continues to improve, creating new opportunities for top executives.